Last updated: August 2026
Global rank: Worldwide · 2026-08
#23,977
AI visibility: Grade A+
94
SEO health: Latest audit
79
Visits
101.8K
per month, estimated
Keywords
9.5K
ranking in Google
Organic share
100%
101.8K organic visits
LLMS.txt
Published
152 lines AI engines can read
You're seeing the free preview of gene.com
gene.com Web Traffic Statistics
Key findings
- Genentech (Biotechnology) is ranked #23,977 worldwide in our August 2026 domain ranking, inside the top 100,000, up 1,116 places from #25,093 in July 2026.
- It is estimated to receive about 101,800 visits a month from search, 100% of it organic, across 9,478 ranking keywords.
- Its AI visibility score is 94 out of 100 (grade A+), with a published llms.txt of 152 lines.
- Its last technical audit scored 79/100, with "Implement H1 Tags" the highest-priority fix.
| Month | Rank | Move |
|---|---|---|
| August 2026 | #23,977 | ▲ 1,116 |
| July 2026 | #25,093 | ▼ 975 |
| June 2026 | #24,118 | — |
| May 2026 | #24,118 | ▼ 268 |
| April 2026 | #23,850 | ▼ 3,093 |
| March 2026 | #20,757 | ▼ 246 |
| February 2026 | #20,511 | — |
What this company does
Genentech is a biotechnology company that develops medicines for people dealing with serious illnesses. Their work involves research into biological processes and the creation of therapies that target particular diseases. Over the years, they have brought forward a range of products used in medical practice, with an emphasis on conditions like cancer and immune system disorders. The company operates as part of a larg…
Our read on the site
The overall SEO health of gene.com is moderate, with room for significant improvement, particularly in on-page elements such as headings and content depth. While technical aspects like HTTPS and viewport are correctly implemented, the lack of H1 tags and low performance score indicate critical areas needing attention.
gene.com Traffic and Visitor Engagement
gene.com draws an estimated 101,800 visits a month from search engines. Effectively all of it is organic — about 101,800 visits from unpaid results. Spread across 9,478 ranking keywords, that averages roughly 11 organic visits per keyword.
Monthly visits
101.8K
Latest estimate
Change
No monthly history yet
It starts building from the first scan
Organic visits
101.8K
100% of all traffic
Paid visits
0
No paid search detected
Organic vs paid
100%
0%
We don't hold a month-by-month history for this domain yet.
The traffic dashboard builds one from the first scan onwards.
gene.com AI Visibility
On our AI visibility scale gene.com earns 94 of 100 points, a grade A+. It takes full marks for LLMS.txt, Crawlability and Structured data. The biggest gap is Company profile, at 22 of 25 points (7/8 core fields), worth 3 points if closed. It also loses points on SEO health (17/20).
Grade A+
Scored from this domain's own data — llms.txt, profile completeness, technical health, crawlability and structured data.
Present
7/8 core fields
85/100
robots ✓ · sitemap ✓
Detected
Fix these first
- → Complete your company profile so AI answers about you stay accurate.
gene.com LLMS.txt
The llms.txt on gene.com runs to 152 lines (6,921 characters) across 12 sections, last generated in March 2026. It introduces the site as "Genentech Official Website". It tells AI engines the business works in Biotechnology, Pharmaceuticals and Healthcare Technology. It describes 4 products, including Rituxan, Herceptin and Avastin. Services it lists include Patient Support Services, Clinical Trials and Population Health Programs. The audience it names is Patients, Healthcare Professionals, Researchers, Biotechnology Firms, aged All ages (Global). Technologies it mentions include HTML5, CSS3, JavaScript, Cloudflare and Google Analytics. The keywords it claims start with "Genentech", "biotechnology", "pharmaceuticals" and "healthcare innovation". It gives the company type as Public and says it is hiring.
Status
Published
AI engines can read it
Lines
152
In the file
Size
6.9K
Characters
Sections
12
Updated Mar 11, 2026
What the file says
# Genentech Official Website ## About Genentech is a pioneering biotechnology company dedicated to developing innovative medicines for serious medical conditions. With a strong focus on scientific research and patient care, the company creates groundbreaking therapies in oncology, immunology, and neuroscience. Genentech serves a global market, leveraging advanced technologies to deliver personalized treatments that transform patients' lives. **Areas of Work:** Biotechnology, Pharmaceuticals, Healthcare Technology ## Things to Remember - **Website:** https://gene.com - **Address:** 1 DNA Way, South San Francisco, CA 94080, United States - **Contact:** [email protected] - **Phone:** +1-650-225-1000 - **Hours:** Mon-Fri: 9AM-5PM - **Timezone:** America/Los_Angeles - **Currency:** USD - **Company Type:** Public - **Employees:** 15000 employees - **Revenue:** $26.1B - **Hiring Status:** Yes, actively hiring ## Products - **Rituxan** (Contact for pricing): A monoclonal antibody therapy used to treat certain autoimmune diseases and types of cancer, including non-Hodgkin's lymphoma. - **Herceptin** (Contact for pricing): A targeted therapy for HER2-positive breast cancer, designed to inhibit the growth of cancer cells. - **Avastin** (Contact for pricing): A treatment for various types of cancer, including colorectal and lung cancer, by inhibiting tumor blood vessel growth. - **Ocrevus*
Sections in the file
Areas of work
Keywords it claims
Technologies
Products it tells AI about
- RituxanContact for pricing
- HerceptinContact for pricing
- AvastinContact for pricing
- OcrevusContact for pricing
Services it tells AI about
- Patient Support ServicesContact for quote
- Clinical TrialsFree participation
- Population Health ProgramsContact for quote
Competitors it names
Audience it targets
Patients, Healthcare Professionals, Researchers, Biotechnology Firms · All ages · Global
Company type
Public · actively hiring
gene.com Organic Keywords
Google lists gene.com for about 9,478 keywords, which together bring an estimated 101,800 organic visits a month.
Ranking keywords
9.5K
Found in Google for this domain
Visits they bring
101.8K
Estimated organic visits a month
Top ranking keywords
No ranked-keyword data cached for this domain yet.
Ranked Keywords pulls the full list on its first run.
What it ranks for
gene.com SEO Audit
The latest technical audit of gene.com scored 79 out of 100 overall. Performance is its weakest area at 48, while accessibility scores highest at 88. The audit makes 12 recommendations in all, and 3 of the 4 listed first are rated high priority or critical.
Overall
SEO
Performance
Accessibility
Fix these first
- CriticalImplement H1 Tags
- HighEnhance Meta Descriptions
- CriticalImprove Page Load Speed
- MediumCreate a Sitemap
8 more recommendations, with the exact changes and the pages they apply to, are in the full report.
gene.com Competitors and Alternatives
Genentech's company profile names amgen.com, biogen.com and regeneron.com as competitors. Its own llms.txt adds abbvie.com, bms.com and rocopharma.com. Outside its market, the domains ranked closest to it in our worldwide ranking are xgroovy-fr.com, kcra.com, convertilo.com and animegojoo.com.
gene.com Company Profile
Genentech is a biotechnology company that develops medicines for people dealing with serious illnesses. Their work involves research into biological processes and the creation of therapies that target particular diseases. Over the years, they have brought forward a range of products used in medical practice, with an emphasis on conditions like cancer and immune system disorders. The company operates as part of a larg…
Genentech was founded in 1976, about 50 years ago, and is headquartered in South San Francisco, United States. Its workforce is listed as between 10,001 and 50,000 employees. Its founders are Herbert Boyer and Robert Swanson. Its profile files it under Biotechnology, with further tags for Pharmaceuticals, Healthcare Technology and B2B. Products on record for it: Rituxan, Herceptin, Avastin and Ocrevus. Reported revenue is $26.1B (2022), and total funding is listed at $1.5B. Its tagline reads: "Breakthrough science. One moment, one day, one person at a time.".
- Sector
- Biotechnology
- Headquarters
- South San Francisco, United States
- Founded
- 1976
- Employees
- 10001-50000
- Revenue
- $26.1B (2022)
- Funding
- $1.5B
- Founders
- Herbert Boyer, Robert Swanson
- Products
- Rituxan, Herceptin, Avastin, Ocrevus
gene.com Traffic by Country
Which markets this brand actually serves, and where the web links to it from.
Top customer markets
AI estimate · live webWe only measure visitor geography for domains whose analytics are connected to us. For everyone else this is read live from the web and shown as an estimate — never mixed in with the measured numbers.
No market breakdown available for this brand.
Where its backlinks come from
Measured. The country each linking site is hosted in — a real signal of which regions know this brand.
No backlink sample for this domain yet.
Backlink Analytics collects one on its first run.
gene.com Backlink Analytics
Who vouches for this domain. Strong, varied links are still the clearest signal of authority — to search engines and to AI engines that cite sources.
We haven't run a backlink crawl for gene.com yet, so there are no link counts to show. Backlink Analytics builds the profile on its first run and it appears here after that.
—
links on file
Companies ranked next to gene.com
Neighbours of #23,977 in our worldwide ranking — each with its own report.
Wait — let's zoom out.
You are looking at one domain. gene.com competes in a market, and the same numbers exist for everyone in it — including the sites AI engines recommend instead of yours. Amrut.ai reads all of them, so you can see who is winning, why, and what to change first.
Everything above, for your own domainand the plan to fix it
Run the free scan on your site and get its AI visibility score, its gaps, and the exact next steps.
Look up another company
A brand name or a domain — the whole overview loads in seconds.